| # | Title | Journal | Year | Citations |
|---|
|
| 1 | Genomic hallmarks of localized, non-indolent prostate cancer | Nature | 2017 | 485 |
| 2 | Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers | Urology | 2005 | 399 |
| 3 | Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up | Annals of Oncology | 2019 | 358 |
| 4 | Serum Prostate Specific Antigen as Pre-Screening Test for Prostate Cancer | Journal of Urology | 1992 | 341 |
| 5 | Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes | BJU International | 2014 | 290 |
| 6 | Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling | Molecular Cancer Research | 2018 | 216 |
| 7 | Treatment of Prostate Cancer with Gonadotropin-Releasing Hormone Agonists | Endocrine Reviews | 1986 | 179 |
| 8 | Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience | BJU International | 2011 | 162 |
| 9 | Impact of histological variants on oncological outcomes of patients with urothelial carcinoma of the bladder treated with radical cystectomy | European Journal of Cancer | 2013 | 160 |
| 10 | Multi-Institutional Validation of the Predictive Value of Ki-67 Labeling Index in Patients With Urinary Bladder Cancer | Journal of the National Cancer Institute | 2009 | 144 |
| 11 | Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: The Canadian PIE Study | Urology | 2005 | 140 |
| 12 | A LATS biosensor screen identifies VEGFR as a regulator of the Hippo pathway in angiogenesis | Nature Communications | 2018 | 129 |
| 13 | Evaluation of fluorodeoxyglucose positron‐emission tomography with computed tomography for staging of urothelial carcinoma | BJU International | 2010 | 111 |
| 14 | Assessing Cancer Risk on Novel 29 MHz Micro-Ultrasound Images of the Prostate: Creation of the Micro-Ultrasound Protocol for Prostate Risk Identification | Journal of Urology | 2016 | 110 |
| 15 | Gender-specific Differences in Clinicopathologic Outcomes Following Radical Cystectomy: An International Multi-institutional Study of More Than 8000 Patients | European Urology | 2014 | 104 |
| 16 | Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer | JAMA Oncology | 2015 | 101 |
| 17 | ImmunoCyt/uCyt+™ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma | Modern Pathology | 2005 | 96 |
| 18 | Prospective Pilot Study of Mirabegron in Pediatric Patients with Overactive Bladder | European Urology | 2016 | 79 |
| 19 | Laparoscopic Management of Ureteral Endometriosis: The Stanford University Hospital Experience With 96 Consecutive Cases | Journal of Urology | 2009 | 70 |
| 20 | p53 expression in patients with advanced urothelial cancer of the urinary bladder | BJU International | 2010 | 69 |
| 21 | CUA guidelines on the management of non-muscle invasive bladder cancer | Canadian Urological Association Journal | 2015 | 69 |
| 22 | Benefits of Combination Therapy with Flutamide in Patients Relapsing after Castration | British Journal of Urology | 1988 | 68 |
| 23 | A multicenter, prospective, randomized clinical trial comparing tension‐free vaginal tape surgery and no treatment for the management of stress urinary incontinence in elderly women | Neurourology and Urodynamics | 2007 | 67 |
| 24 | Carcinoma of the upper urinary tract | Cancer | 2009 | 65 |
| 25 | Prospective Open Label Study of Solifenacin for Overactive Bladder in Children | Journal of Urology | 2010 | 57 |
| 26 | Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL | Canadian Urological Association Journal | 2013 | 56 |
| 27 | Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015 | Canadian Urological Association Journal | 2016 | 55 |
| 28 | Safety and outcome of early catheter removal after radical retropubic prostatectomy | Urology | 2004 | 54 |
| 29 | Molecular Markers in Key Steroidogenic Pathways, Circulating Steroid Levels, and Prostate Cancer Progression | Clinical Cancer Research | 2013 | 54 |
| 30 | Genome-wide germline correlates of the epigenetic landscape of prostate cancer | Nature Medicine | 2019 | 54 |
| 31 | Canadian Urological Association guideline: Muscle-invasive bladder cancer | Canadian Urological Association Journal | 2018 | 53 |
| 32 | Surveillance guidelines based on recurrence patterns after radical cystectomy for bladder cancer: the Canadian Bladder Cancer Network experience | BJU International | 2012 | 51 |
| 33 | FDG-PET/CT for pre-operative staging and prognostic stratification of patients with high-grade prostate cancer at biopsy | Cancer Imaging | 2015 | 50 |
| 34 | Continuous monitoring of intrapelvic pressure during flexible ureteroscopy using a sensor wire: a pilot study | World Journal of Urology | 2021 | 50 |
| 35 | Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma | Canadian Urological Association Journal | 2013 | 49 |
| 36 | Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: Assessment of adequate renal function and influence on outcome | Urologic Oncology: Seminars and Original Investigations | 2014 | 49 |
| 37 | Double Anticholinergic Therapy for Refractory Overactive Bladder | Journal of Urology | 2009 | 47 |
| 38 | Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: Results from the Canadian Upper Tract Collaboration1Co-first authors. | Urologic Oncology: Seminars and Original Investigations | 2014 | 47 |
| 39 | Canadian guidelines for the management of the small renal mass (SRM) | Canadian Urological Association Journal | 2015 | 45 |
| 40 | Colonic Neoplasms Following Ureterosigmoidostomy | Journal of Urology | 1975 | 44 |
| 41 | Dual Therapy for Refractory Overactive Bladder in Children: A Prospective Open-Label Study | Journal of Urology | 2017 | 41 |
| 42 | Donor-Specific Antibodies, C4d and Their Relationship With the Prognosis of Transplant Glomerulopathy | Transplantation | 2015 | 39 |
| 43 | The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System | Urologic Oncology: Seminars and Original Investigations | 2016 | 39 |
| 44 | Factors predicting overall success: a review of 747 microsurgical vasovasostomies | Canadian Urological Association Journal | 2013 | 38 |
| 45 | COMPARISON OF MOLECULAR AND CONVENTIONAL STRATEGIES FOR FOLLOWUP OF SUPERFICIAL BLADDER CANCER USING DECISION ANALYSIS | Journal of Urology | 2000 | 37 |
| 46 | Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling | British Journal of Cancer | 2012 | 35 |
| 47 | Long-term use of solifenacin in pediatric patients with overactive bladder: Extension of a prospective open-label study | Canadian Urological Association Journal | 2014 | 35 |
| 48 | Dual-Kidney Transplants as an Alternative for Very Marginal Donors: Long-Term Follow-Up in 63 Patients | Transplantation | 2010 | 34 |
| 49 | Expression of p21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomy | International Journal of Cancer | 2001 | 33 |
| 50 | Surgical Option for the Correction of Peyronie's Disease: An Autologous Tissue-Engineered Endothelialized Graft | Journal of Sexual Medicine | 2011 | 33 |
